Herpes Simplex Virus Type 2 Acquisition Among HIV-1–Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study

OBJECTIVE. Tenofovir disoproxyl fumarate (TDF) disoproxyl fumarate (TDF) has in vitro activity against herpes simplex virus type 2 (HSV-2) and reduced HSV-2 acquisition as preexposure prophylaxis. Whether TDF-containing antiretroviral therapy (ART) reduces HSV-2 acquisition is unknown. DESIGN. Secon...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Infect Dis
Huvudupphovsmän: Celum, Connie, Hong, Ting, Cent, Anne, Donnell, Deborah, Morrow, Rhoda, Baeten, Jared M., Firnhaber, Cynthia, Grinsztejn, Beatriz, Hosseinipour, Mina C., Lalloo, Umesh, Nyirenda, Mulinda, Riviere, Cynthia, Sanchez, Jorge, Santos, Breno, Supparatpinyo, Khuanchai, Hakim, James, Kumarasamy, N., Campbell, Thomas B.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2017
Ämnen:
Brief Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5406847/
https://ncbi.nlm.nih.gov/pubmed/28453835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix029
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk